Penicillium marneffei infection presenting as an immune reconstitution inflammatory syndrome in an HIV patient

International Journal of STD and AIDS

Volumn 21, Issue 11, 2010, Pages 780-782

  Ho, A ^a   Shankland, G S ^b   Seaton, R A ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

HIV; Immune reconstitution inflammatory syndrome; Immune restoration disease; Penicillium marneffei

Indexed keywords

AMPHOTERICIN B; C REACTIVE PROTEIN; COTRIMOXAZOLE; EFAVIRENZ; EMTRICITABINE; HEMOGLOBIN; ITRACONAZOLE; LOPINAVIR PLUS RITONAVIR; TENOFOVIR;

ADULT; ANOREXIA; ARTICLE; BLOOD CULTURE; CASE REPORT; COUGHING; DIARRHEA; DYSPNEA; ERYTHEMA; FACE ERYTHEMA; FEVER; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HETEROSEXUAL MALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEUKOCYTE COUNT; MALE; MOLLUSCUM CONTAGIOSUM; MYCOSIS; PANCYTOPENIA; PENICILLIUM MARNEFFEI; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWEAT; TACHYCARDIA; VOMITING; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; DERMATOMYCOSES; FACE; FACIAL DERMATOSES; FOREHEAD; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; PENICILLIUM; PHENOTYPE; RNA, VIRAL; VIRAL LOAD;

EID: 78650851422     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010164     Document Type: Article

References (13)

1. Huiras E, Preda V, Maurer T, Whitfield M. Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS 2008;3:453-60
2. Ustianowski AP, Sieu TPM, Day JN. Penicillium marneffei infection in HIV. Curr Opin Inf Dis 2008;21:31-6
3. Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycosis in the immunocompromised host. Transpl Infect Dis 2006;8:128-39
4. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994;344:110-3
5. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;26:1107-10
6. Supparatpinyo K, Perriens J, Nelson KE, Sirsanthana T. A controlled trial of itraconazole to prevent relapse of Penicilium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998;339:1739-43
7. Chaiwarith R, Charoenyos N, Sirsanthana T, Supparatpinyo K. Discontinuation of secondary prophylaxis against Penicilliosis marneffei in AIDS patients after HAART. AIDS 2007;21:365-7
8. Dhasmana DJ, Dheda K, Ravn P, Wilkinson R, Meintjes G. Immune reconstitution inflammatory syndrome in HIV-infected patients - pathogenesis, clinical manifestations and management. Drugs 2008;68:191-208
9. Elston JWT, Thaker H. Immune reconstitution inflammatory syndrome. Int J STD AIDS 2009;20:221-4
10. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007;7:395-401 (Pubitemid 46765196)
11. Gupta S, Mathur P, Maskey D, Wig N, Singh S. Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. AIDS Res Ther 2007;4:21-4
12. Saikia L, Nath R, Hazarika D, Mahanta J. Penicillium marneffei infection in HIV infected patients in Nagaland & immune reconstitution after treatment. Indian J Med Res 2009;129:333-4
13. Saikia L, Nath R, Hazarika D, Mahanta J. Atypical cutaneous lesions of Penicillium marneffei infection as a manifestation of the immune reconstitution inflammatory syndrome after highly active antiretroviral therapy. Indian J Dermatol Venereol Leprol 2010;76:45-8